148 related articles for article (PubMed ID: 8774148)
1. Pathogenesis of skin lesions in mice with chronic proliferative dermatitis (cpdm/cpdm).
Gijbels MJ; Zurcher C; Kraal G; Elliott GR; HogenEsch H; Schijff G; Savelkoul HF; Bruijnzeel PL
Am J Pathol; 1996 Mar; 148(3):941-50. PubMed ID: 8774148
[TBL] [Abstract][Full Text] [Related]
2. Absence of Peyer's patches and abnormal lymphoid architecture in chronic proliferative dermatitis (cpdm/cpdm) mice.
HogenEsch H; Janke S; Boggess D; Sundberg JP
J Immunol; 1999 Apr; 162(7):3890-6. PubMed ID: 10201907
[TBL] [Abstract][Full Text] [Related]
3. Expression of chitinase-like proteins in the skin of chronic proliferative dermatitis (cpdm/cpdm) mice.
HogenEsch H; Dunham A; Seymour R; Renninger M; Sundberg JP
Exp Dermatol; 2006 Oct; 15(10):808-14. PubMed ID: 16984263
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of chemokines in the skin of chronic proliferative dermatitis mutant mice.
Renninger ML; Seymour R; Lillard JW; Sundberg JP; HogenEsch H
Exp Dermatol; 2005 Dec; 14(12):906-13. PubMed ID: 16274458
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic interventions in mice with chronic proliferative dermatitis (cpdm/cpdm).
Gijbels MJ; Elliott GR; HogenEsch H; Zurcher C; van den Hoven A; Bruijnzeel PL
Exp Dermatol; 2000 Oct; 9(5):351-8. PubMed ID: 11016856
[TBL] [Abstract][Full Text] [Related]
6. Maintenance of donor phenotype after full-thickness skin transplantation from mice with chronic proliferative dermatitis (cpdm/cpdm) to C57BL/Ka and nude mice and vice versa.
Gijbels MJ; HogenEsch H; Bruijnzeel PL; Elliott GR; Zurcher C
J Invest Dermatol; 1995 Dec; 105(6):769-73. PubMed ID: 7490470
[TBL] [Abstract][Full Text] [Related]
7. Topical suplatast tosilate (IPD) ameliorates Th2 cytokine-mediated dermatitis in caspase-1 transgenic mice by downregulating interleukin-4 and interleukin-5.
Murakami T; Yamanaka K; Tokime K; Kurokawa I; Tsutsui H; Nakanishi K; Mizutani H
Br J Dermatol; 2006 Jul; 155(1):27-32. PubMed ID: 16792748
[TBL] [Abstract][Full Text] [Related]
8. The development of atopic dermatitis is independent of Immunoglobulin E up-regulation in the K14-IL-4 SKH1 transgenic mouse model.
Chen L; Overbergh L; Mathieu C; Chan LS
Clin Exp Allergy; 2008 Aug; 38(8):1367-80. PubMed ID: 18489026
[TBL] [Abstract][Full Text] [Related]
9. Toxicology and carcinogenesis studies of indium phosphide (CAS No. 22398-90-7) in F344/N rats and B6C3F1 mice (inhalation studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2001 Jul; (499):7-340. PubMed ID: 12087422
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous application of peptidoglycan from Staphylococcus aureus induces an increase in mast cell numbers in the dermis of mice.
Matsui K; Nishikawa A
Clin Exp Allergy; 2005 Mar; 35(3):382-7. PubMed ID: 15784119
[TBL] [Abstract][Full Text] [Related]
11. IFN-γ or IFN-α ameliorates chronic proliferative dermatitis by inducing expression of linear ubiquitin chain assembly complex.
Tamiya H; Terao M; Takiuchi T; Nakahara M; Sasaki Y; Katayama I; Yoshikawa H; Iwai K
J Immunol; 2014 Apr; 192(8):3793-804. PubMed ID: 24634492
[TBL] [Abstract][Full Text] [Related]
12. A spontaneous mutation characterized by chronic proliferative dermatitis in C57BL mice.
HogenEsch H; Gijbels MJ; Offerman E; van Hooft J; van Bekkum DW; Zurcher C
Am J Pathol; 1993 Sep; 143(3):972-82. PubMed ID: 8362989
[TBL] [Abstract][Full Text] [Related]
13. CCL27-transgenic mice show enhanced contact hypersensitivity to Th2, but not Th1 stimuli.
Kagami S; Saeki H; Tsunemi Y; Nakamura K; Kuwano Y; Komine M; Nakayama T; Yoshie O; Tamaki K
Eur J Immunol; 2008 Mar; 38(3):647-57. PubMed ID: 18266301
[TBL] [Abstract][Full Text] [Related]
14. Stress-induced modulation of skin immune function: two types of antigen-presenting cells in the epidermis are differentially regulated by chronic stress.
Nakano Y
Br J Dermatol; 2004 Jul; 151(1):50-64. PubMed ID: 15270872
[TBL] [Abstract][Full Text] [Related]
15. Essential role of MHC II-independent CD4+ T cells, IL-4 and STAT6 in contact hypersensitivity induced by fluorescein isothiocyanate in the mouse.
Takeshita K; Yamasaki T; Akira S; Gantner F; Bacon KB
Int Immunol; 2004 May; 16(5):685-95. PubMed ID: 15096484
[TBL] [Abstract][Full Text] [Related]
16. Changes in keratin and filaggrin expression in the skin of chronic proliferative dermatitis (cpdm) mutant mice.
HogenEsch H; Boggess D; Sundberg JP
Pathobiology; 1999; 67(1):45-50. PubMed ID: 9873228
[TBL] [Abstract][Full Text] [Related]
17. Primary immune response in skin and skin-associated lymphoid tissue of interleukin-4 transgenic mice.
Blümel J; Schimpl A; Ulrich P; Ahr HJ; Vohr H
Eur Cytokine Netw; 1999 Dec; 10(4):515-24. PubMed ID: 10586118
[TBL] [Abstract][Full Text] [Related]
18. Mast cells and vasculature in atopic dermatitis--potential stimulus of neoangiogenesis.
Groneberg DA; Bester C; Grützkau A; Serowka F; Fischer A; Henz BM; Welker P
Allergy; 2005 Jan; 60(1):90-7. PubMed ID: 15575937
[TBL] [Abstract][Full Text] [Related]
19. P- and E-selectins are required for the leukocyte recruitment, but not the tissue swelling, associated with IgE- and mast cell-dependent inflammation in mouse skin.
de Mora F; Williams CM; Frenette PS; Wagner DD; Hynes RO; Galli SJ
Lab Invest; 1998 Apr; 78(4):497-505. PubMed ID: 9564894
[TBL] [Abstract][Full Text] [Related]
20. Animal model of sclerotic skin. II. Bleomycin induced scleroderma in genetically mast cell deficient WBB6F1-W/W(V) mice.
Yamamoto T; Takahashi Y; Takagawa S; Katayama I; Nishioka K
J Rheumatol; 1999 Dec; 26(12):2628-34. PubMed ID: 10606374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
